» Articles » PMID: 6426464

Stimulus-response Coupling in Human Platelets. Changes Evoked by Platelet-activating Factor in Cytoplasmic Free Calcium Monitored with the Fluorescent Calcium Indicator Quin2

Overview
Journal Biochem J
Specialty Biochemistry
Date 1984 Mar 15
PMID 6426464
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The role of changes in cytoplasmic free calcium, [Ca2+]i, in the responses to platelet-activating factor (PAF) was studied in human platelets loaded with the fluorescent calcium indicator, quin2. In the presence of 1 mM external calcium, PAF raised [Ca2+]i 8-10-fold in a few seconds to peak near 1 microM. [Ca2+]i then declined over several minutes towards the basal level. In the absence of external calcium there was a much smaller increase in [Ca2+]i of similar pattern. These findings suggest that PAF increases [Ca2+]i partly by discharge of internal Ca2+, but mainly by stimulated influx. Blockade of cyclo-oxygenase with aspirin only slightly reduced the [Ca2+]i changes, indicating that thromboxane A2 is not a major mediator of the calcium movements. In control conditions PAF could stimulate shape-change, aggregation and secretion. Aggregation and secretion were roughly halved by blockade of cyclo-oxygenase. Shape-change and secretion still occurred under conditions where the [Ca2+]i rise was small or suppressed, indicating a role for intracellular activators other than Ca2+. The possible involvement of products of phosphoinositide breakdown is discussed.

Citing Articles

Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells.

Brailoiu E, Barlow C, Ramirez S, Abood M, Brailoiu G Neuroscience. 2018; 377:105-113.

PMID: 29522856 PMC: 5882569. DOI: 10.1016/j.neuroscience.2018.02.039.


Involvement of Nitric Oxide on Calcium Mobilization and Arachidonic Acid Pathway Activation during Platelet Aggregation with different aggregating agonists.

Banerjee D, Mazumder S, Sinha A Int J Biomed Sci. 2016; 12(1):25-35.

PMID: 27127451 PMC: 4841983.


Aspirin prophylaxis for the prevention of thrombosis: expectations and limitations.

Rao G, Fareed J Thrombosis. 2012; 2012:104707.

PMID: 22448319 PMC: 3289854. DOI: 10.1155/2012/104707.


Aspirin resistance: A fact or a myth?.

Rao G Exp Clin Cardiol. 2009; 10(1):17-20.

PMID: 19641662 PMC: 2716223.


Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.

Riganti C, Doublier S, Viarisio D, Miraglia E, Pescarmona G, Ghigo D Br J Pharmacol. 2009; 156(7):1054-66.

PMID: 19298255 PMC: 2697684. DOI: 10.1111/j.1476-5381.2009.00117.x.


References
1.
Hendrickson H . Physical properties and interactions of phosphoinositides. Ann N Y Acad Sci. 1969; 165(2):668-76. View

2.
Aster R, JANDL J . PLATELET SEQUESTRATION IN MAN. I. METHODS. J Clin Invest. 1964; 43:843-55. PMC: 289563. DOI: 10.1172/JCI104970. View

3.
Henson P . Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response. J Exp Med. 1976; 143(4):937-52. PMC: 2190171. DOI: 10.1084/jem.143.4.937. View

4.
Costa J, DETWILER T, Feinman R, Murphy D, PATLAK C, Pettigrew K . Quantitative evaluation of the loss of human platelet dense bodies following stimulation by thrombin or A23187. J Physiol. 1977; 264(1):297-306. PMC: 1307759. DOI: 10.1113/jphysiol.1977.sp011669. View

5.
Demopoulos C, Pinckard R, HANAHAN D . Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem. 1979; 254(19):9355-8. View